Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
DAWN | US
-0.38
-2.71%
Healthcare
Biotechnology
30/06/2024
02/10/2024
13.62
13.91
13.91
13.41
Day One Biopharmaceuticals Inc. a clinical-stage biopharmaceutical company develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101 an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals Inc. was incorporated in 2018 and is headquartered in Brisbane California.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Weakness based on declining price with high volume
Price Below SMA10D
Smallcap (300M - 2B USD)
Low negative Beta, possible Low Liquidity (< -0.4)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
37.3%1 month
39.6%3 months
45.2%6 months
59.0%-
-
4.54
0.00
0.00
-7.18
125.78
-
-287.17M
1.34B
1.34B
-
-1.40K
-
-
-45.71
18.62
18.66
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.50
Range1M
1.75
Range3M
4.22
Rel. volume
1.42
Price X volume
17.85M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Ocular Therapeutix Inc | OCUL | Biotechnology | 9.31 | 1.45B | 2.76% | n/a | 19.83% |
Cassava Sciences Inc | SAVA | Biotechnology | 26.94 | 1.45B | -1.75% | n/a | 0.00% |
Kura Oncology Inc | KURA | Biotechnology | 18.5 | 1.42B | -3.70% | n/a | 3.59% |
Longboard Pharmaceuticals Inc. Common Stock | LBPH | Biotechnology | 36.42 | 1.42B | -1.81% | n/a | 1.31% |
NRIX | NRIX | Biotechnology | 21.97 | 1.42B | -0.54% | n/a | 7.77% |
Arcus Biosciences Inc | RCUS | Biotechnology | 15.39 | 1.41B | -0.19% | n/a | 1.73% |
SPRY | SPRY | Biotechnology | 14.45 | 1.40B | -0.07% | n/a | 0.07% |
Xencor Inc | XNCR | Biotechnology | 19.46 | 1.36B | -0.92% | n/a | 15.54% |
Wave Life Sciences Ltd | WVE | Biotechnology | 8.83 | 1.31B | 6.39% | n/a | 656.70% |
Tarsus Pharmaceuticals Inc | TARS | Biotechnology | 32.75 | 1.27B | 1.42% | n/a | 28.62% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Steelcase Inc | SCS | Building Products & Equipment | 12.87 | 1.46B | -2.50% | 12.50 | 65.47% |
REV Group Inc | REVG | Recreational Vehicles | 27.56 | 1.43B | 1.29% | 6.15 | 63.13% |
Janus International Group Inc. | JBI | Building Products & Equipment | 9.53 | 1.38B | -1.45% | 11.54 | 116.21% |
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.79 | 1.22B | -1.02% | n/a | -571.93% |
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 11.46 | 1.15B | -2.47% | n/a | 19.46% |
Camping World Holdings Inc | CWH | Recreational Vehicles | 23.53 | 1.06B | -1.96% | n/a | 3644.76% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 39.97 | 799.03M | 2.70% | n/a | 1.50% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.64 | 767.43M | -0.30% | 61.27 | 77.00% |
Ennis Inc | EBF | Building Products & Equipment | 23.75 | 617.12M | -2.98% | 15.15 | 2.42% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.26 | 503.90M | -1.87% | n/a | 174.23% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -7.18 | 0.76 | Cheaper |
Ent. to Revenue | 125.78 | 3,674.48 | Cheaper |
PE Ratio | - | 38.01 | - |
Price to Book | 4.54 | 14.10 | Cheaper |
Dividend Yield | - | 2.22 | - |
Std. Deviation (3M) | 45.17 | 74.67 | Lower Risk |
Debt to Equity | 0.00 | -1.82 | Expensive |
Debt to Assets | 0.00 | 0.26 | Cheaper |
Market Cap | 1.34B | 3.73B | Emerging |